Recent News

Can an individual receive the therapy as often as desired, or in their own home?

By Al Harlow | November 5, 2017

SAIDO Learning has been determined to be the most effective when performed five times per week. It is most successful when performed in a residential community where older adults receive ongoing staff support from all disciplines. The therapy is currently not available in the home.

What are the chances that people’s dementia symptoms may not improve after participating?

By Al Harlow | November 5, 2017

All of the Learners in the Eliza Jennings trial experienced some degree of improvement in at least one of the two standardized tests for cognitive ability, the FAB, and the MMSE.

How long will it take to see results? Are the changes permanent?

By Al Harlow | November 5, 2017

Whether great or small, we are seeing positive changes within the first month of participation. Improvements resulting from participation are likely to continue throughout the duration of the older adults’ sessions.

Are there eligibility requirements to participate?

By Al Harlow | November 5, 2017

A successful candidate is an individual with a diagnosis of moderate-stage dementia who is able to participate in therapy sessions. The therapy can also be provided bedside for individuals whose cognitive impairments are more severe.

Who can benefit from this therapy?

By Al Harlow | November 5, 2017

An individual with any form and/or stage of dementia (other than alcohol-induced dementia) can benefit.

What is SAIDO Learning and where is it available?

By Al Harlow | November 5, 2017

SAIDO Learning is a groundbreaking, non-pharmaceutical intervention that has been shown to reduce and even reverse symptoms of dementia. It is based on the concept that engaging in simple yet specific therapy, which stimulates the prefrontal cortex, can reverse symptoms of dementia. SAIDO Learning is currently available through Eliza Jennings.

Brain cell death mechanism for stroke, Alzheimer’s identified

By Al Harlow | November 4, 2017

“Different triggers spark stroke, injuries, and neurodegenerative diseases, but the molecular chain of events responsible for brain cell death in these conditions are the same. Johns Hopkins researchers have isolated the single protein at the end of the chain that delivers the fatal blow and hacks up a cell’s DNA.” Read more of this article…

Renaissance / Falls-Lenox “Bulldog Buddies” Honored by LeadingAge Ohio with Excellence in Volunteer Service Award

By Al Harlow | November 1, 2017

MEDIA RELEASE For Immediate Release August 11, 2017 Contact: Linda Hart Director of Public Relations 216.325.1250 or lhart@elizajen.org (Cleveland, Ohio) – The “Bulldog Buddies” mentoring program, a collaboration between the Renaissance Retirement Campus (an Eliza Jennings community in Olmsted Township) and Falls-Lenox Primary School (Olmsted Falls City Schools), was recognized this week with the Excellence…

Eliza Jennings Board of Trustees Appoints 2018-20 Officers

By Al Harlow | November 1, 2017

MEDIA RELEASE For Immediate Release August 11, 2017 Contact: Linda Hart Director of Public Relations 216.325.1250 or lhart@elizajen.org Eliza Jennings Board of Trustees Appoints 2018-20 Officers (Cleveland, Ohio) – Eliza Jennings, a nationally recognized and trusted expert in aging services, announced the appointment of officers to the Board of Trustees for the fiscal 2018 –…

What is a Continuing Care Retirement Community?

By Al Harlow | October 30, 2017

A Continuing Care Retirement Community (CCRC) offers older adults the ability to “age in place” by providing independent living, assisted living and nursing care accommodations, usually on the same property, with the ability to transfer between these residences as needs change in the future. A CCRC typically provides independent living residents with a service package…